May is Brain Tumor Awareness Month Melanoma cells are one of the most common cancers that can migrate to the brain, creating a new challenge for…
Apr. 19, 2026 KIMMTRAK doubles the likelihood of being alive at five years for firstline HLA-A*02:01+ patients with metastatic uveal melanoma
Apr. 10, 2026 FDA Does Not Approve RP1 in Combination with Nivolumab for Advanced Melanoma: What This Means for Patients